Search Results - "Introna, M"

Refine Results
  1. 1

    CIK as therapeutic agents against tumors by Introna, M.

    Published in Journal of autoimmunity (01-12-2017)
    “…Cytokine Induced Killer (CIK) cells are ex vivo expanded and activated T lymphocytes obtained by sequential incubation of Peripheral Blood Mononuclear cells…”
    Get full text
    Journal Article
  2. 2

    Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches by Rambaldi, A, Biagi, E, Bonini, C, Biondi, A, Introna, M

    Published in Leukemia (01-01-2015)
    “…When treatment fails, the clinical outcome of acute leukemia patients is usually very poor, particularly when failure occurs after transplantation. A second…”
    Get full text
    Journal Article
  3. 3

    Localization of Mesenchymal Stromal Cells Dictates Their Immune or Proinflammatory Effects in Kidney Transplantation by Casiraghi, F., Azzollini, N., Todeschini, M., Cavinato, R. A., Cassis, P., Solini, S., Rota, C., Morigi, M., Introna, M., Maranta, R., Perico, N., Remuzzi, G., Noris, M.

    Published in American journal of transplantation (01-09-2012)
    “…Multipotent mesenchymal stromal cells (MSC) have recently emerged as promising candidates for cell‐based immunotherapy in solid‐organ transplantation. However,…”
    Get full text
    Journal Article
  4. 4

    Clinical grade expansion of MSCs by Capelli, C, Pedrini, O, Valgardsdottir, R, Da Roit, F, Golay, J, Introna, M

    Published in Immunology letters (01-12-2015)
    “…Highlights • The use of MSCs as advanced-therapy medicinal products is at the front line of stem cell-based therapies. • The requirements for MSCs clinical…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Cytokine Induced Killer (CIK) cells for the treatment of haematological neoplasms by Introna, M, Golay, J, Rambaldi, A

    Published in Immunology letters (01-09-2013)
    “…Abstract Cytokine Induced Killer (CIK) cells are in vitro activated human CD8 T cells which have maintained several characteristics of T-EMRA cells and…”
    Get full text
    Journal Article
  7. 7

    Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts by CAPELLI, C, DOMENGHINI, M, BORLERI, G, BELLAVITA, P, POMA, R, CAROBBIO, A, MICO, C, RAMBALDI, A, GOLAY, J, INTRONA, M

    Published in Bone marrow transplantation (Basingstoke) (01-10-2007)
    “…We compared two protocols for the expansion of human mesenchymal stromal cells (hMSCs) starting from diagnostic samples of BM aspirates (2-5 ml) or using the…”
    Get full text
    Journal Article
  8. 8

    Low-fiber alfalfa (Medicago sativa L.) meal in the laying hen diet: Effects on productive traits and egg quality by Laudadio, V., Ceci, E., Lastella, N. M. B., Introna, M., Tufarelli, V.

    Published in Poultry science (01-07-2014)
    “…This study was designed to determine the effects on laying performance and egg quality resulting from partial substitution of soybean meal (SBM) with low-fiber…”
    Get full text
    Journal Article
  9. 9

    Suitability of partly destoned exhausted olive cake as by-product feed ingredient for lamb production by Tufarelli, V, Introna, M, Cazzato, E, Mazzei, D, Laudadio, V

    Published in Journal of animal science (01-02-2013)
    “…The effect of diets with different levels of partly destoned exhausted olive cake (PDEOC) on growth performance and carcass traits of Gentile di Puglia breed…”
    Get full text
    Journal Article
  10. 10

    First Report of a Successful Pregnancy in an Everolimus‐Treated Heart‐Transplanted Patient: Neonatal Disappearance of Immunosuppressive Drugs by Fiocchi, R., D'Elia, E., Vittori, C., Sebastiani, R., Strobelt, N., Eleftheriou, G., Introna, M., Freddi, C., Crippa, A.

    Published in American journal of transplantation (01-04-2016)
    “…The use of everolimus (EVL) as primary immunosuppression is steadily increasing in heart transplantation (HTx) patients. Limited data currently exist in kidney…”
    Get full text
    Journal Article
  11. 11

    The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2 by Guerini, V, Barbui, V, Spinelli, O, Salvi, A, Dellacasa, C, Carobbio, A, Introna, M, Barbui, T, Golay, J, Rambaldi, A

    Published in Leukemia (01-04-2008)
    “…We investigated the activity of ITF2357, a novel histone deacetylase inhibitor (HDACi) with antitumor activity, on cells carrying the JAK2(V617F) mutation…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Production of low-fiber sunflower (Helianthus annuus L.) meal by micronization and air classification processes by Laudadio, V., Bastoni, E., Introna, M., Tufarelli, V.

    Published in CYTA: journal of food (01-11-2013)
    “…Sunflower (Heliantus annuus L.) meal is an important by-product as a source of vegetable protein and fiber for humans and animals; however, its nutritional…”
    Get full text
    Journal Article
  15. 15

    Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone by Di Gaetano, N., Xiao, Y., Erba, E., Bassan, R., Rambaldi, A., Golay, J., Introna, M.

    Published in British journal of haematology (01-09-2001)
    “…We have shown previously that the anti‐CD20 chimaeric monoclonal antibody rituximab exerts its effects on neoplastic B‐lymphoma cell lines in part via…”
    Get full text
    Journal Article
  16. 16

    Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation by INTRONA, M, FRANCESCHETTI, M, CIOCCA, A, BORLERI, G, CONTI, E, GOLAY, J, RAMBALDI, A

    Published in Bone marrow transplantation (Basingstoke) (01-11-2006)
    “…We have used a standardized 21-day expansion protocol to produce cytokine-induced killer (CIK) cells starting from very small amounts of nucleated cells…”
    Get full text
    Journal Article
  17. 17

    The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells by GOLAY, J, CUPPINI, L, POZZI, P, PORRO, G, PAGANI, P, FOSSATI, G, MASCAGNI, P, INTRONA, M, RAMBALDI, A, LEONI, F, MICO, C, BARBUI, V, DOMENGHINI, M, LOMBARDI, L, NERI, A, BARBUI, A. M, SALVI, A

    Published in Leukemia (01-09-2007)
    “…We have investigated the activity of ITF2357, a novel hydroxamate histone deacetylase inhibitor, on multiple myeloma (MM) and acute myelogenous leukemia (AML)…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease by Serafini, M, Manganini, M, Borleri, G, Bonamino, M, Imberti, L, Biondi, A, Golay, J, Rambaldi, A, Introna, M

    Published in Human gene therapy (01-01-2004)
    “…We have previously proposed the CD20 molecule as a novel suicide gene for T lymphocytes in the context of allogeneic bone marrow transplantation, because CD20…”
    Get more information
    Journal Article
  20. 20

    Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA) by Luchetti, M. M., Piccinini, G., Mantovani, A., Peri, G., Matteucci, C., Pomponio, G., Fratini, M., Fraticelli, P., Sambo, P., Di Loreto, C., Doni, A., Introna, M., Gabrielli, A.

    Published in Clinical and experimental immunology (01-01-2000)
    “…PTX3 is a secreted molecule which consists of a C‐terminal domain similar to classical pentraxins (e.g. C‐reactive protein (CRP)) and of an unrelated…”
    Get full text
    Journal Article